The primary clinical endpoint was the fasting insulin level and the homeostatic model assessment of insulin resistance (HOMA-IR) index. The secondary endpoint was the oral glucose tolerance test (OGTT). These are clinical measures used to assess insulin resistance and glucose metabolism.